Source 1review2022Biological Chemistry
Toolkit/photopharmacology
photopharmacology
Also known as: caging-photoswitchable molecules, photopharmacology
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Photopharmacology is an engineering method that uses chemically engineered small-molecule photosensitive effectors to impose light control over biological targets. In the cited literature, it is identified as one of the major strategies for targeted photocontrol in proteins and as an optical approach for modulating adrenergic receptor signaling with temporal and spatial precision.
Usefulness & Problems
Why this is useful
This method is useful because it enables optical modulation of signaling processes with precise temporal and spatial resolution. The cited review further states that optical control approaches including photopharmacology can enhance understanding of adrenergic signaling and may support future therapeutic development.
Source:
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Source:
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Problem solved
Photopharmacology addresses the problem of how to control protein function and signaling pathways with light rather than constitutive or diffusely applied perturbations. In the provided evidence, this is framed specifically as targeted photocontrol in proteins and optical modulation of adrenergic receptor signaling.
Source:
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Source:
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Published Workflows
Objective: Develop photoresponsive molecular tools suitable for clinical light-based applications.
Why it works: The review states that envisioned clinical scenarios are used to define the properties photoresponsive tools should possess, then discusses optimization of photochemical parameters and pharmacological aspects needed for medical deployment.
light responsivenesstranslation of photonic stimulus into biological effectcontrol of biological functionapplication-scenario-driven property specificationphotochemical parameter optimizationpharmacological property optimization
Stages
- 1.Define clinical application scenarios(decision_gate)
The review first describes envisioned clinical scenarios and uses them to determine what properties photoresponsive tools should have.
Selection: envisioned clinical practice scenarios
- 2.Optimize photochemical parameters(functional_characterization)
The abstract states that optimization of key photochemical parameters is necessary to enable application in the medical field.
Selection: key photochemical performance parameters
- 3.Assess pharmacological suitability(secondary_characterization)
The review gives an outlook on toxicity, solubility, and stability, indicating that these properties are important translational constraints for light-responsive molecules.
Selection: pharmacological aspects relevant to translation
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete method used to build, optimize, or evolve an engineered system.
Target processes
recombinationsignalingInput: Light
Implementation Constraints
Implementation relies on chemical engineering of small-molecule photosensitive effectors and the application of light as the input modality. The supplied evidence does not provide specific wavelengths, chromophores, delivery methods, or construct-design requirements.
The provided review notes that current optical tools for adrenergic signaling have limitations and discusses next-generation optogenetic and photopharmacological tools. However, the supplied evidence does not specify the exact technical limitations, performance bounds, or failure modes for photopharmacology itself.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2primary paper2026MED
Source 3review2016Current Opinion in Pharmacology
Source 4review2025Medicinal Research Reviews
Ranked Claims
Combining optical biosensing with photopharmacology enhances analysis of GPCR signaling dynamics and function with minimal perturbation.
the combination of optical biosensing and photopharmacology enhances our ability to analyze GPCR signaling dynamics and function with minimal perturbation
These light-based approaches open new avenues for targeted research and therapeutic interventions in β-adrenoceptor-related diseases.
these approaches open new avenues for targeted research and therapeutic interventions, offering a powerful framework for understanding β-adrenoceptors-related diseases
Photopharmacology and optogenetics enable precise external modulation of β-adrenoceptor activity.
photopharmacology and optogenetics enable precise external modulation of their activity
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
These optical techniques targeting specific members of the GPCR signaling pathway provide a broad base for investigating GPCR signaling in behavior and disease states and may support therapeutic development.
These emerging techniques targeting specific members of the GPCR signaling pathway offer an expansive base for investigating GPCR signaling in behavior and disease states, in addition to paving a path to potential therapeutic developments.
Optogenetics provides means to control cell signaling with spatiotemporal control in discrete cell types.
Optogenetics has revolutionized neuroscience by providing means to control cell signaling with spatiotemporal control in discrete cell types.
Cre-dependent viral vector expression and two-photon microscopy are highlighted as technologies to utilize these optical tools in vitro and in vivo.
we highlight technologies to utilize these tools in vitro and in vivo, including Cre dependent viral vector expression and two-photon microscopy
The review organizes optical manipulation of neuromodulatory GPCR signaling into four major tool classes: opsins including engineered chimeric receptors, photoactivatable proteins, photopharmacology using caged or photoswitchable molecules, and fluorescent protein-based reporters and biosensors.
we summarize four major classes of optical tools to manipulate neuromodulatory GPCR signaling: opsins (including engineered chimeric receptors); photoactivatable proteins; photopharmacology through caging-photoswitchable molecules; fluorescent protein based reporters and biosensors
Approval Evidence
4 sources12 linked approval claimsfirst-pass slugs photopharmacology, photopharmacology-through-caging-photoswitchable-molecules
Photopharmacology and optogenetics enable precise external modulation of their activity.
Source:
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Source:
For the targeted design of photocontrol in proteins, three major methods have been developed over the last decades, which employ either chemical engineering of small-molecule photosensitive effectors (photopharmacology)...
Source:
photopharmacology through caging-photoswitchable molecules
Source:
advantagesupports
Combining optical biosensing with photopharmacology enhances analysis of GPCR signaling dynamics and function with minimal perturbation.
the combination of optical biosensing and photopharmacology enhances our ability to analyze GPCR signaling dynamics and function with minimal perturbation
Source:
application potentialsupports
These light-based approaches open new avenues for targeted research and therapeutic interventions in β-adrenoceptor-related diseases.
these approaches open new avenues for targeted research and therapeutic interventions, offering a powerful framework for understanding β-adrenoceptors-related diseases
Source:
capabilitysupports
Photopharmacology and optogenetics enable precise external modulation of β-adrenoceptor activity.
photopharmacology and optogenetics enable precise external modulation of their activity
Source:
application potentialsupports
Emerging optical technologies for adrenergic signaling are described as enhancing understanding of adrenergic signaling and paving the way for potential therapeutic developments.
These emerging optical technologies not only enhance our understanding of AR signaling but also pave the way for potential therapeutic developments.
Source:
limitation and outlooksupports
Current optical tools for adrenergic signaling have limitations, and the review discusses next-generation optogenetic and photopharmacological tools.
We also discuss the limitations of current tools and provide an outlook on the next generation of optogenetic and photopharmacological tools.
Source:
review scope summarysupports
Optogenetics and photopharmacology are presented as optical control techniques that can modulate adrenergic receptor signaling with precise temporal and spatial resolution.
The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution.
Source:
application scopesupports
Artificial photocontrol of proteins is described as being of growing interest for scientific investigation at organismal, cellular, and molecular levels and for development of medicinal drugs or biocatalytic tools.
Source:
comparative review statementsupports
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
Source:
review scope summarysupports
The review identifies three major methods for targeted design of photocontrol in proteins: photopharmacology, photoxenoprotein engineering, and hybrid protein optogenetics.
Source:
application scopesupports
These optical techniques targeting specific members of the GPCR signaling pathway provide a broad base for investigating GPCR signaling in behavior and disease states and may support therapeutic development.
These emerging techniques targeting specific members of the GPCR signaling pathway offer an expansive base for investigating GPCR signaling in behavior and disease states, in addition to paving a path to potential therapeutic developments.
Source:
capability summarysupports
Optogenetics provides means to control cell signaling with spatiotemporal control in discrete cell types.
Optogenetics has revolutionized neuroscience by providing means to control cell signaling with spatiotemporal control in discrete cell types.
Source:
review scope summarysupports
The review organizes optical manipulation of neuromodulatory GPCR signaling into four major tool classes: opsins including engineered chimeric receptors, photoactivatable proteins, photopharmacology using caged or photoswitchable molecules, and fluorescent protein-based reporters and biosensors.
we summarize four major classes of optical tools to manipulate neuromodulatory GPCR signaling: opsins (including engineered chimeric receptors); photoactivatable proteins; photopharmacology through caging-photoswitchable molecules; fluorescent protein based reporters and biosensors
Source:
Comparisons
Source-backed strengths
The evidence supports precise temporal and spatial control as a key advantage of photopharmacological approaches. It is also described as a major established category within targeted protein photocontrol, indicating broad conceptual utility as a design strategy.
Source:
The review compares the different methods, their strategies, and their current applications for light regulation of proteins and provides background information useful for implementing each technique.
Ranked Citations
- 1.
- 2.
- 3.
- 4.